Stem Cell Therapy International, Inc. (SCII) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 7 transactions totaling $4.3K, demonstrating a bearish sentiment with -$2.3K in net insider flow. The most recent transaction on Sep 16, 2009 involved a sale of 5,000 shares valued at $1.6K.
No significant insider buying has been recorded for SCII in the recent period.
No significant insider selling has been recorded for SCII in the recent period.
Based on recent SEC filings, insider sentiment for SCII is bearish with an Insider Alignment Score of 23/100 and a net flow of -$2.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Stem Cell Therapy International, Inc. (SCII) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading SCII stock, having executed 7 transactions in the past 90 days. The most active insider is David Stark (Executive), who has made 3 transactions totaling $61.0K.
Get notified when executives and directors at SCII file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 16, 2009 | Chau Thuy-van | Executive | Sale | 5,000 | $0.33 | $1.6K | |
| Sep 16, 2009 | Chau Thuy-van | Executive | Sale | 5,000 | $0.33 | $1.6K | |
| Jul 27, 2009 | Stark David | Executive | Award | 1,000,000 | $0.06 | $60.0K | |
| Jul 27, 2009 | James Norstrud Andrew | Executive | Award | 1,000,000 | $0.06 | $60.0K | |
| Dec 11, 2008 | Stark David | Executive | Purchase | 1,462 | $0.06 | $88 | |
| Dec 11, 2008 | Stark David | Executive | Purchase | 12,500 | $0.07 | $875 | |
| Mar 25, 2008 | Cao Calvin | Executive | Other | 900,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 2 | $120.0K | 96.6% |
Sale(S) | 2 | $3.3K | 2.7% |
Purchase(P) | 2 | $963 | 0.8% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at Stem Cell Therapy International, Inc. has increased, with 4 insiders executing 7 transactions across all time. Total sales of $3.3K significantly outpace purchases of $963, resulting in a net outflow of $2.3K. This selling activity appears largely discretionary, which may warrant closer attention from investors.